EMEA-002936-PIP01-20

Key facts

Active substance
Anti-alpha-synuclein human monoclonal antibody
Therapeutic area
Neurology
Decision number
P/0136/2021
PIP number
EMEA-002936-PIP01-20
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
  • Treatment of multiple system atrophy
  • Treatment of Parkinson's disease
Route(s) of administration
Intravenous use
Contact for public enquiries
H. Lundbeck A/S

E-mail: tsbr@lundbeck.com
Tel.  +45 30834928

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating